Changing the FDA Approval Process

Susan Desmond-Hellmann, UCSF

Loading video...

Susan Desmond-Hellmann, chancellor of UCSF, has a big idea to change the drug approval process at the Food and Drug Administration (FDA). The current process is binary, allowing for only a yes or no from the reviewer for drug approval. Desmond-Hellmann suggests that a variable approval process, that can change status as greater evidence comes in over time, will encourage more innovative products and even investment funding, based on product confidence.

Feb 2, 2011

More from this event

More on this topic